Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. METHODS AND RESULTS: Patients in the acute coronary treatment and intervention outcomes network (A...

Full description

Saved in:
Bibliographic Details
Published in:J Am Heart Assoc
Main Authors: Basra, Sukhdeep S., Wang, Tracy Y., Simon, DaJuanicia N., Chiswell, Karen, Virani, Salim S., Alam, Mahboob, Nambi, Vijay, Denktas, Ali E., Deswal, Anita, Bozkurt, Biykem, Ballantyne, Christie M., Peterson, Eric D., Jneid, Hani
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220549/
https://ncbi.nlm.nih.gov/pubmed/29886424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008125
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items